Practice Areas - Debt Capital Markets Law Firms and Lawyers
| Deal Date: | 01-05-2015 | Practice Area: | Debt Capital Markets |
| Deal Title: | Amgen Offering of Registered Notes due 2020, due 2022, due 2045 | Industry: | Pharmaceuticals & Biotechnology |
| Description: |
Shearman and Sterling represented Morgan Stanley, BofA Merrill Lynch, Credit Suisse, Goldman, Sachs and Co., Barclays, Citigroup, Deutsche Bank Securities, JP Morgan and SMBC Nikko as joint book-running managers in connection with Amgen's registered offering of USD3.5 billion of investment grade notes, consisting of USD750,000,000 of 2.125% senior notes due 2020, USD500,000,000 of 2.700% senior notes due 2022, USD1,000,000,000 of 3.125% senior notes due 2025 and USD1,250,000,000 of 4.400% senior notes due 2045. Amgen is a global biotechnology company that discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology.
The following Shearman and Sterling team advised the underwriters in the transaction: partners John Wilson (San Francisco-Capital Markets), Alan Seem (San Francisco-Capital Markets), Laurence Crouch (Menlo Park-Tax) and Richard Hsu (Menlo Park-IP).
|
||
| Financial Center: | San Francisco | Value: | 1000.01-5000.00 |
| Advised Party: | Lead Manager | Law Firm | Shearman & Sterling |
| Issuer Jurisdiction | United States | Listing Jurisdiction | United States |
| Classification: |
Corporate Bonds Senior Debt |
Lawyer | John D Wilson |
